Emergent BioSolutions (NYSE:EBS) Shares Gap Down on Disappointing Earnings
Emergent BioSolutions Inc. (NYSE:EBS – Get Rating) gapped down before the market opened on Tuesday after the company announced weaker than expected quarterly earnings. The stock had previously closed at $14.00, but opened at $13.27. Emergent BioSolutions shares last traded at $12.15, with a volume of 395,192 shares traded. The biopharmaceutical company reported ($0.31) earnings […]